Juniper Pharma (Formerly known as Columbia Laboratories)
4 Liberty Square
Boston
Massachusetts
02109
United States
Tel: 617-639-1500
Website: http://www.juniperpharma.com/
Email: enquiry@juniperpharma.com
274 articles about Juniper Pharma (Formerly known as Columbia Laboratories)
-
Columbia Laboratories, Inc. Expands Its Intellectual Property Portfolio Following Receipt Of U.S. Patent
7/17/2014
-
Columbia Laboratories, Inc. Added To The Russell Microcap Index
6/26/2014
-
Columbia Laboratories, Inc. Reports First Quarter 2014 Financial Results
4/29/2014
-
Columbia Laboratories, Inc. To Discuss First Quarter 2014 Financial Results On April 29th Conference Call
4/17/2014
-
Columbia Laboratories, Inc. Repurchases 1.4 Million Shares Of Common Stock From Actavis
3/7/2014
-
Columbia Laboratories, Inc. Reports Fourth Quarter And Full Year 2013 Financial Results
3/5/2014
-
Columbia Laboratories, Inc. Announces Board Changes
3/3/2014
-
Columbia Laboratories, Inc. To Discuss Fourth Quarter And Year End 2013 Financial Results On March 5 Conference Call
2/26/2014
-
Columbia Laboratories, Inc. Announces Restatement Of Previously- Issued Unaudited Interim Consolidated Financial Statements For The Three- And Nine-Month Periods Ended September 30, 2013
2/20/2014
-
Columbia Laboratories, Inc. To Present February 11th At Biotechnology Industry Organization (BIO) CEO & Investor Conference
2/4/2014
-
Columbia Laboratories, Inc. Announces Preliminary Fourth Quarter And Year-End 2013 Results
1/9/2014
-
Luzich Partners Releases Open Letter To Columbia Laboratories, Inc. Shareholders
1/6/2014
-
Columbia Laboratories, Inc. To Receive One-Time Payment From Actavis for CRINONE U.S. Manufacturing Rights
11/14/2013
-
Columbia Laboratories, Inc. Reports Third Quarter 2013 Financial Results
11/7/2013
-
Columbia Laboratories, Inc. to Discuss Third Quarter 2013 Financial Results on November 7 Conference Call
10/24/2013
-
Amended Class Action Lawsuit Against Columbia Laboratories, Inc. Dismissed Without Prejudice
10/23/2013
-
Columbia Laboratories, Inc. Expands Board of Directors
9/16/2013
-
Columbia Laboratories, Inc. Acquires Molecular Profiles, a U.K.-Based Provider of Pharmaceutical Formulation Development and Manufacturing Services
9/12/2013
-
Columbia Laboratories, Inc. Regains Compliance With NASDAQ Listing Standards
8/26/2013
-
Columbia Laboratories, Inc. Reports Second Quarter 2013 Financial Results
8/7/2013